In conjunction with the IAS Conference on HIV Science, Frontier Biotechnologies announced positive top-line results for its phase 3 TALENT study, which demonstrated that an ABT-based two-drug treatment arm was non-inferior to a lopinavir (LPV)-based ...
Frontier Pharma and Baystone Group today announced the completion of its acquisition of Zdravlje A.D from Teva Pharmaceuticals. Zdravlje currently supplies high quality pharmaceuticals to more than 35 international markets including those in ...